Benitec Biopharma Inc. (BNTC)
Nasdaq: BNTC · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Period ending | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 |
| Report filed | Sep 14, 2026 | Sep 22, 2025 | Sep 26, 2024 | Sep 21, 2023 | Sep 2, 2022 | Sep 20, 2021 | Sep 23, 2020 | · |
| Revenue | · | · | 0 | 75 | 73 | 59 | 97 | 11,551 |
| Research and development | 23,388 | 18,332 | 15,609 | 12,774 | 11,272 | 7,020 | 3,001 | 4,567 |
| General and administrative | 27,804 | 23,433 | 6,989 | 6,382 | 6,646 | 6,512 | 5,567 | 4,614 |
| Total operating expenses | 51,192 | 41,765 | 22,490 | 19,156 | 17,927 | 13,655 | 8,383 | 9,616 |
| Operating income | -51,192 | -41,765 | -22,490 | -19,081 | -17,854 | -13,596 | -8,281 | 2,583 |
| Interest income (expense), net | 5,569 | 3,286 | 904 | -33 | -32 | -6 | 62 | 122 |
| Other income (expense), net | -43 | -131 | -204 | -30 | -79 | 37 | 34 | · |
| Total non-operating income (expense) | 5,646 | 3,848 | 739 | -481 | -354 | -286 | 7 | 26 |
| Income tax expense | 0 | · | · | · | · | · | · | · |
| Net income | -45,546 | -37,917 | -21,751 | -19,562 | -18,208 | -13,882 | -8,274 | 2,609 |
| Net income to common shareholders | -45,546 | -37,917 | -22,370 | -19,562 | · | · | · | · |
| Earnings per share, basic | -0.98 | -1.05 | -1.22r | -3.1195b | -8.3688rb | -12.1313b | · | · |
| Earnings per share, diluted | -0.98 | -1.05 | -1.22r | -3.1195b | -8.3688rb | -12.1313b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -12.1313b | -30.4221b | 11.4552b |
| Weighted average shares, basic | 46,558,162 | 36,209,271 | 18,364,386r | 6,272,650b | 2,175,746rb | 1,143,671b | · | · |
| Weighted average shares, diluted | 46,558,162 | 36,209,271 | 18,364,386r | 6,272,650b | 2,175,746rb | 1,143,671b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 1,143,671b | 271,897b | 228,117b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the change of share basis.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted